Cempra to Receive BARDA Funding for 1b and Start-Up of Phase 2/3 Solithromycin Pediatric Studies $16.0 Million Will be Provided to Cover the Cost of the Study and Other Activities Specified in the Contract Phase 1b and Phase 2/3 Studies Will Test Intravenous, Oral Capsule and Oral Suspension...